A detailed history of Steward Partners Investment Advisory, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 4,045 shares of TGTX stock, worth $130,249. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,045
Holding current value
$130,249
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.21 - $25.28 $69,614 - $102,257
4,045 New
4,045 $94,000
Q4 2022

Feb 15, 2023

BUY
$5.01 - $11.83 $1,252 - $2,957
250 New
250 $2,000
Q2 2021

Aug 13, 2021

SELL
$32.5 - $48.96 $32,500 - $48,960
-1,000 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$41.61 - $54.3 $41,610 - $54,300
1,000 New
1,000 $48,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.68B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.